| BENZOYL PEROXIDE | None | ||
| 5 |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| EPZICOM, a combination of abacavir and lamivudine, both nucleoside analogue HIV-1 reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. | |||
|
Yes
| |||
| EPSOLAY | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||||
| ************ *** *** ********* ** ******* | ***** ***** ******* ** ***** ********* *********** | ****** *** ********* ** ******* ** ******** **** ** ***** *** ***** | ****** *** ********* ***** ***** ** ****** ** *** ********* ** ******* | ****** *** ****-**** ********* ** ******* | ****** *** ********* ** ******* | ****** *** *********** ********* ** ******* | ****** *** ********* ** ******* ** ******** **** ** ***** *** ***** | ****** *** ********* ***** ***** ** ****** ** *** ********* ** ******* | ****** *** ********* ** ******* | ****** *** ********* ********* ********** ***** ***** ******* *** ********* **** ***** ***** ******* | ********** *************, ****** ** ***** *********** *** **** ******* | ****** *** *********** ********* ** ******* | ****** *** ********* ********* ********** ***** ***** ******* *** ********* **** ***** ***** ******* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|